Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

ObjectiveTo evaluate the characteristics of patients with autoimmune disease with hypogammaglobulinemia following rituximab (RTX) and describe their long-term outcomes, including those who commenced immunoglobulin replacement therapy.MethodsPatients received RTX for autoimmune disease between 2003 a...

Full description

Bibliographic Details
Main Authors: Joanna Tieu, Rona M. Smith, Seerapani Gopaluni, Dinakantha S. Kumararatne, Mark McClure, Ania Manson, Sally Houghton, David R. W. Jayne
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
rituximab
hypogammaglobulinemia
autoimmune disease
immunoglobulin replacement therapy
B-cell
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.671503/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.671503/full

Similar Items